Stay updated on Nivolumab Combo in Head & Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in Head & Neck Cancer Clinical Trial page.

Latest updates to the Nivolumab Combo in Head & Neck Cancer Clinical Trial page
- Check5 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1, a minor metadata change with no impact on study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoChange DetectedThe page shows minor UI and metadata updates, including a 'Show glossary' option and a revision label of v3.4.0, along with capitalization normalization of 'Last Update' QC criteria and 'No FEAR Act data' wording. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4, appearing in the page footer; this is a minor system update and does not affect study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedAdded a Pennsylvania location in the Locations section. Removed the older Pennsylvania Locations wording.SummaryDifference0.2%

- Check76 days agoChange DetectedThe page footer now shows Revision: v3.3.2, replacing Revision: v3.2.0.SummaryDifference0.1%

- Check84 days agoChange DetectedThe government funding/operating status notice near the bottom of the ClinicalTrials.gov page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Nivolumab Combo in Head & Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Head & Neck Cancer Clinical Trial page.